Author:
Raval A D,Thakker D,Vyas A,Salkini M,Madhavan S,Sambamoorthi U
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Reference36 articles.
1. Holman R . Metformin as first choice in oral diabetes treatment: The UKPDS experience. J Annu Diabetol Hotel Dieu 2007, 13–20.
2. Yin M, Zhou J, Gorak EJ, Quddus F . Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: A systematic review and meta-analysis. Oncologist 2013; 18: 20.
3. Zhang P, Li H, Tan X, Chen L, Wang S . Association of metformin use with cancer incidence and mortality: A meta-analysis. Cancer Epidemiology 2013; 37: 207–218.
4. Zhang Z -, Li S . The prognostic value of metformin for cancer patients with concurrent diabetes: A systematic review and meta-analysis. Diabetes Obesity Metab 2014; 16: 707–710.
5. Franciosi M, Lucisano G, Lapice E, Strippoli GF, Pellegrini F, Nicolucci A . Metformin therapy and risk of cancer in patients with type 2 diabetes: Systematic review. PLoS One 2013; 8: e71583.
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献